Indian scientist sheds light on new treatment for heart disease in diabetics

Image
ANI Washington DC
Last Updated : Aug 13 2015 | 12:42 PM IST

In a breakthrough discovery, an Indian scientist has found new treatment for heart disease in diabetics by targeting a key protein.

Lead researcher Rajesh Katare of the University of Otago said that the team sought to confirm their laboratory-based results by collaborating with cardiothoracic surgeons at Dunedin Hospital to collect and study heart tissue samples from coronary bypass patients.

In the study, the researchers used the type-2 diabetic mouse model and matched around 35 such diabetic patients to comparable non-diabetic ones. Analysis revealed markedly increased autophagy in the diabetic patients' heart tissues compared to the non-diabetic ones.

The increase then triggered activation of pro-cell death proteins, which lead to progressive loss of cardiac cells. As more cells die, cardiac dysfunction develops and heart failure ensues.

They also identified that diabetes increases autophagy through activation of the protein (Beclin-1).

Katare said that the protein presented an extremely promising target for new treatments of diabetes-related cardiac disease.

He said that they found that these molecular alterations begun in the diabetic heart from an early stage of the disease, before any clinically identifiable symptoms, so blocking them could be useful in combating cardiovascular complications in diabetes.

The study is published in the International Journal of Cardiology.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 13 2015 | 12:34 PM IST

Next Story